Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (SHA:603707)
China · Delayed Price · Currency is CNY 7.70
-0.21 (-2.65%)
Sep 24, 2026, 3:00 PM CST
SHA:603707 Market Cap
SHA:603707 has a market cap or net worth of 12.43 billion as of September 25, 2026. Its market cap has decreased by -26.80% in one year.
Market Cap
12.43B
Enterprise Value
11.55B
Revenue
3.94B
Ranking
n/a
PE Ratio
25.54
Stock Price
7.70
ChartMarket Cap Chart
Since July 19, 2017, SHA:603707's market cap has increased from 4.40B to 12.43B, an increase of 182.76%. That is a compound annual growth rate of 11.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 12.43B | -14.80% |
| Dec 31, 2025 | 14.59B | -31.95% |
| Dec 31, 2024 | 21.44B | -11.29% |
| Dec 29, 2023 | 24.17B | -16.87% |
| Dec 30, 2022 | 29.08B | -44.15% |
| Dec 31, 2021 | 52.06B | 59.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 19, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Guobang Pharma | 13.97B |
| China Resources Jiangzhong Pharmaceutical Co.,Ltd | 13.94B |
| Zhejiang Hisun Pharmaceutical | 13.24B |
| Porton Pharma Solutions | 12.78B |
| Shenzhen Hepalink Pharmaceutical Group | 12.69B |
| PharmaBlock Sciences (Nanjing) | 12.13B |
| Beijing Aosaikang Pharmaceutical | 11.69B |
| Zhejiang Medicine | 11.69B |